Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Private equity firms acquiring top CMOs at a rapid rate: GlobalData
GlobalData’s report states that PE-backed CMOs will find they have a lot more financial support to add to their service offerings…
Biocon Biologics and Viatris receive US FDA approval for maiden interchangeable biosimilar Semglee
Interchangeable designation allows substitution at the pharmacy counter for Lantus across the US to help increase access to…
Covishield gives 93 per cent protection against COVID and 98 per cent mortality reduction: AFMC
Addressing a press conference, Dr V K Paul, Member (Health), NITI Aayog, presented findings of the study which was conducted on 15…
India underinvests in science
Unless we build more than simply two or three global centres of scientific excellence and training, and unless we reward our…
Role of pharmacovigilance in innovating and revolutionising healthcare accessibility in India
Dr Pramod Dhembare, Founder and Managing Partner, Fidelity Health Service, traces the role of pharmacovigilance in public…
Gilead Sciences launches Asia Pacific All4LIVER Grant 2021
The grant aims to empower organisations that can help bring liver health, in particular, viral hepatitis, to the forefront of…
High Commissioner of India visits Wockhardt UK
The High Commissioner was provided with a tour of the vaccine fill-finish facility which is currently contracted by the UK…
Emcure Pharma appoints four new directors
The new members’ collective strength across legal, pharma spectrum, policy developments and academics will provide additional…
Alembic Pharma Q1 net profit declines to Rs 165 cr
The company had posted a net profit of Rs 301.46 crores for the corresponding period of the previous fiscal, Alembic…
Biocon Biologics and Adagio Therapeutics to develop antibody treatment for COVID-19
Biocon Biologics to manufacture and commercialise a broadly neutralising antibody for India and select emerging markets